Would you consider upfront, time-limited anti-IL-5 therapy for I-HES or L-HES to avoid steroid side effects?
Steroids are often recommended upfront with slow taper over weeks/months with repeat evaluation to see if there is rebound eosinophilia. However, the prolonged exposure to steroids come with a number of side effects. Has your practice moved towards trying a time-limited anti-IL-5 therapy upfront instead?
Community PollStarted
What is your preferred first line therapy for I-HES or L-HES?
4 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Hematology · Dalhousie University, Canada
Answered on
There are two parts to this question:
- Are there better options than steroids for the treatment of iHES and L-HES? The answer is an emphatic yes. These are chronic diseases, and steroids are really not the optimal therapy. IL-5 inhibitors such as mepolizumab and benralizumab are effective in reducing flares and steroid exposures, but are expensive. Other therapies to consider include pegylated interferon alpha 2a, mycophenolate mofetil, and ruxolitinib (for L-HES).
- Do patients with iHES and L-HES...
Join for free or sign in to see the full answer